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ABSTRACT
Objective. Recognizing the potential impact of psychiatric and psychosocial factors on
liver transplant patient outcomes is essential to apply special follow-up for more vulnerable
patients. The aim of this article was to investigate the psychiatric and psychosocial factors
predicted medical outcomes of liver transplanted patients.
Methods. We studied 150 consecutive transplant candidates, attending our outpatient
transplantation clinic, including 84 who had been grafted 11 of whom died and 3
retransplanted.
Results. We observed that active coping was an important predictor of length of stay
after liver transplantation. Neuroticism and social support were important predictors of
mortality after liver transplantation.
Conclusion. It may be useful to identify patients with low scores for active coping and for
social support and high scores for neuroticism to design special modes of follow-up to






SPREVIOUS investigations concerning predictors of out-comes have focused primarily on medical factors, such
as kind, severity, and treatment of the liver disease.1 Some
authors have shown that psychosocial factors also predict
physical quality of life.1–5 Recognizing the potential impact
of psychiatric and psychosocial factors on liver transplant
patient outcomes is essential, so that special psychiatric and
psychological follow-up can be performed for more vulner-
able patients. This study sought to investigate which psychi-
atric and psychosocial factors measured before transplantation




Among 150 consecutive candidates attending the outpatient trans-
plantation clinics 84 has been transplanted. The study protocol was
approved by the institutional review committee, according to
ethical guidelines of the 1975 Declaration of Helsinki. We accessed
these patients before and through the first year after transplanta-
tion.
Pretransplant Psychosocial and Medical Assessment
To measure the quality of life, we used the Short Form (SF)-36
Portuguese validated version, a self rating questionnaire developed
by the Medical Outcome Trust.6,7 Total values were computed for
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Levels of anxiety and depression were assessed by means of the
Hospital Anxiety and Depression Scale Portuguese version.8,9
Personality traits were assessed by means of the NEO Five-Factor
Inventory (NEO-FFI), Portuguese version.10,11
To access coping mechanisms, we used the Brief COPE Portu-
guese version,12,13 which is designed to provide rapid, reliable, and
alid measures of the 14 domains of coping strategies: self-
istraction, active coping, denial, substance use, use of emotional
upport, use of instrumental support, behavioral disengagement,
enting, positive reframing, planning, humor, acceptance, religion,
nd self-blame. Social support was evaluated by means of The
ocial Support Questionnaire (SSQ6) Portuguese version.13,14
The diagnosis of liver disease was achieved by an hepatologist.
Child-Pugh classification was used to evaluate liver disease severity.
We considered severe liver disease when a patient belonged to
Child Pugh class B or C.
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To measure medical outcomes, we considered the length of
inpatient stay after transplantation, which according to recent
studies is an important marker of transplant success, mortality and
the presence of post-transplantation complications.15
Statistical Methods
Statistical analysis used the SPSS 13.0 for Windows software
package (SPSS, Inc., Chicago, Ill). Predictors of length of inpatient
stay were evaluated by the Pearson correlation and linear regres-
sion, predictors of mortality and presence of posttransplant com-
plications, by means of Mann–Whitney and logistic regression tests.
RESULTS
Demographics and Medical Data
Among the 150 candidates, the average inpatient length of
stay among 84 who were transplanted was 22.4 days. During
the first year after transplantation, 11 patients died: 8 after
surgery, one at 8 months due to viral recidivism; one at 6
months due to extreme generalized edema; and another at
1 year due to decompensation of liver function. Three were
retransplanted and 8 refused to continue in the study; 28
had 1 complication after transplantation (Table 1).
Regarding the medical diagnosis, 25 of them had familial
amyloid polyneuropathy and 59 chronic liver disease. There
were 34 female subjects with an overall mean age of 57.74 
19.34 years. Fifteen patients belonged to Child C class; 22
Child B and the remainder to Child A.
Length of Stay Predictors
Psychosocial factors from the pretransplant period that pre-
sented significant correlations with length of stay were active
coping (Pearson C: 0.35), acceptance (Pearson C: 0.24*)
nd social support (Pearson C: 0.25; Table 2).
A multiple regression model was developed using these
ndependent variables together with demographic factors of
ge, gender, education level, and employment as well as
linical variables of with/without severe liver disease), and
ength of stay as the dependent variable.
Applying a backward elimination method, lead to the
limination of all of the independent variables except active
Table 1. Medical Evolution (n  84)
n












Alcoholic steatosis 1oping and severe liver disease. By means of this model, we
bserved that posttransplant anxiety significantly correlated
ith pretransplant active coping and severe liver disease.
Mortality Predictors
Factors from the pretransplant period that presented sig-
nificant associations with mortality were social support and
neuroticism. A multiple linear model was estimated using
these independent variables along with some demographic
data (age, gender, education level, and employment) and
clinical information (with/without severe liver disease), with
length of stay as the dependent variable. This model
revealed that posttransplant mortality significantly corre-
lated with pretransplant social support (odds ratio [OR],
1.68; P  .05) and neuroticism (OR, 0.88; P  .03) and
almost significantly with severe liver disease (OR, 3.19; P 
.07). For conceptual reasons, we decided to accept statisti-
cal significance at P  .1; therefore, we considered severe
iver disease to be a mortality predictor (Table 3).
Complication Predictors
Our factor from the pretransplant period that presented
significant associations with mortality was depression (z 
2.00; P  .04). A multiple linear model used the above
ndependent variables along with demographic variables
age, gender, education level, and employment) and clinical
ariables (with/without severe liver disease), and the length
f stay as the dependent variable. By means of this model,
e found that posttransplant mortality correlated signifi-
antly only with pretransplant severity of liver disease.
sychosocial variables were excluded from this model.
DISCUSSION
In this work, we found that mortality after liver transplan-
tation was predicted by neuroticism and social support; the
length of stay after transplantation was predicted by active
coping. Our study supports the belief that neurotic person-
ality traits can predict mortality as observed in other clinical
situations.16–19
Active coping has been shown to predict clinical evolu-
tion in other medical situations.20–22
Table 2. Length of Stay Predictors
r  .54
r2  .30 Beta T Sig.
Severe liver disease 8.76 39 .001
Active coping 2.67 34 .005
Linear regression.
Table 3. Mortality Predictors
Logistic Regression Coef SE OR (95% CI) P
Social support .51 .26 1.68 (1.0–2.8) .05
Neuroticism .13 .06 .88 (.78–.99) .03
Severe Liver disease 1.83 1.02 3.19 (.07–6.2) .07
PSYCHIATRIC AND PSYCHOSOCIAL PREDICTORS 157According to our conclusions, it could be important in the
pretransplant period to detect patients with non-adaptive
coping mechanisms and nonadaptive personality traits for
special follow-up seeking to improve their medical evolution
after transplantation.
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